Applicant, as named in the Orange Book
Anacor Pharms Inc
Next listed expiry: Eucrisa on 20 Jul 2030. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
| Eucrisa crisaborole | crisaborole | 207695 | 20 Jul 2030 | patent |
Recent events
- 25 Oct 2026Eucrisa · First generic approved 24 Sep 2026
- 25 Oct 2026Eucrisa · Generic approved 24 Sep 2026